Boston Harbor Angels is the famous VC, which was founded in 2004. The venture was found in North America in United States. The leading representative office of defined VC is situated in the Boston.
The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 1 - 5 millions dollars are the general things for fund. The higher amount of exits for fund were in 2015. This Boston Harbor Angels works on 18 percentage points less the average amount of lead investments comparing to the other organizations. The real fund results show that this VC is 3 percentage points less often commits exit comparing to other companies.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Boston Harbor Angels, startups are often financed by Cherrystone Angel Group, Maine Angels, LaunchPad Venture Group. The meaningful sponsors for the fund in investment in the same round are LaunchPad Venture Group, Mass Medical Angels, Beacon Angels. In the next rounds fund is usually obtained by Maine Angels, Cherrystone Angel Group, LaunchPad Venture Group.
This organization was formed by Mic Williams. Besides them, we counted 2 critical employees of this fund in our database.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Education, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Daktari Diagnostics, KnipBio, Vizibility. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Astrocyte Pharmaceuticals | $6M | 18 Aug 2023 | Cambridge, Massachusetts, United States | ||
Zylö Therapeutics | $5M | 03 Jun 2022 | Greenville, South Carolina, United States | ||
Xeno Biosciences, Inc. | $7M | 08 Aug 2021 | Massachusetts, United States | ||
Astrocyte Pharmaceuticals | $6M | 03 May 2021 | Cambridge, Massachusetts, United States | ||
S'More Date | $2M | 26 Jan 2021 | New York, New York, United States | ||
Enrich Therapeutics | $320K | 15 Jul 2020 | Worcester, Massachusetts, United States | ||
01 Jan 2020 | Bengaluru, Karnataka, India | ||||
Zylö Therapeutics | $4M | 26 Sep 2019 | Greenville, South Carolina, United States | ||
DetraPel | $1M | 12 Sep 2019 | Framingham, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Astrocyte Pharmaceuticals | $6M | 18 Aug 2023 | Cambridge, Massachusetts, United States | ||
Zylö Therapeutics | $5M | 03 Jun 2022 | Greenville, South Carolina, United States | ||
Xeno Biosciences, Inc. | $7M | 08 Aug 2021 | Massachusetts, United States | ||
Astrocyte Pharmaceuticals | $6M | 03 May 2021 | Cambridge, Massachusetts, United States | ||
S'More Date | $2M | 26 Jan 2021 | New York, New York, United States | ||
Enrich Therapeutics | $320K | 15 Jul 2020 | Worcester, Massachusetts, United States | ||
01 Jan 2020 | Bengaluru, Karnataka, India | ||||
Zylö Therapeutics | $4M | 26 Sep 2019 | Greenville, South Carolina, United States | ||
DetraPel | $1M | 12 Sep 2019 | Framingham, Massachusetts, United States |